MicroRNA-122-5p is upregulated in diabetic foot ulcers and decelerates the transition from the inflammatory to the proliferative stage
MicroRNA-122-5p ist bei diabetischen Fußulzera hochreguliert und verlangsamt den Übergang von der inflammatorischen zur proliferativen Phase
World Journal of Diabetes · 15.04.2025 · 16 (4)
DOI: 10.4239/wjd.v16.i4.100113 ↗Auf einen Blick
Bei diabetischen Fußulzera war miR-122-5p in Hautgewebe von Patient:innen und Mäusen erhöht. In Maus- und Zellanalysen war dies mit mehr Entzündung und weniger Fibrose verbunden.
Fragestellung
Welchen Einfluss hat miR-122-5p auf den Übergang von der inflammatorischen zur proliferativen Phase bei diabetischen Fußulzera?
Methode
Analyse der miR-122-5p-Expression in Hautgewebe von Patient:innen und Mäusen mittels qRT-PCR; diabetisches Wundheilungsmodell bei Mäusen; Gewebeentnahme an Tag 3, 7 und 14.
Ergebnisse
MiR-122-5p war in diabetischem Hautgewebe hochreguliert. Es ging mit erhöhten Entzündungsmediatoren und verminderten Fibrosemarkern einher und förderte M1- gegenüber M2-Makrophagen.
Schlussfolgerung der Autor:innen
MiR-122-5p behindert die kutane Heilung diabetischer Mäuse durch Verstärkung der Entzündung und Hemmung der Fibrose und liefert Hinweise auf die Rolle von miRs bei der Wundheilung der Haut.
Kernaussagen
- miR-122-5p war in DFU-Haut von Patient:innen und Mäusen erhöht
- Entzündungsmediatoren stiegen, Fibrosemarker sanken
- M1-Makrophagen nahmen zu, M2-Polarisation nahm ab
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Diabetes, online erschienen am 15.04.2025. Verfasst von Mei-Jie Yuan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Peripheral Vascular Surgery, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, Chin…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetisches Fußsyndrom
Abstract (Originalsprache)
BACKGROUND Shifting from the inflammatory to the proliferative phase represents a pivotal step during managing diabetic foot ulcers (DFUs); however, existing medical interventions remain insufficient. MicroRNAs (miRs) highlight notable capacity for accelerating the repair process of DFUs. Previous research has demonstrated which miR-122-5p regulates matrix metalloproteinases under diabetic conditions, thereby influencing extracellular matrix dynamics. AIM To investigate the impact of miR-122-5p on the transition from the inflammatory to the proliferative stage in DFU. METHODS Analysis for miR-122-5p expression in skin tissues from diabetic ulcer patients and mice was analyzed using quantitative real-time polymerase chain reaction (qRT-PCR). A diabetic wound healing model induced by streptozotocin was used, with mice receiving intradermal injections of adeno-associated virus -DJ encoding empty vector or miR-122. Skin tissues were retrieved at 3, 7, and 14 days after injury for gene expression analysis, histology, immunohistochemistry, and network studies. The study explored miR-122-5p’s role in macrophage-fibroblast interactions and its effect on transitioning from inflammation to proliferation in DFU healing. RESULTS High-throughput sequencing revealed miR-122-5p as crucial for DFU healing. qRT-PCR showed significant upregulation of miR-122-5p within diabetic skin among DFU individuals and mice. Western blot, along with immunohistochemical and enzyme-linked immunosorbent assay, demonstrating the upregulation of inflammatory mediators (hypoxia inducible factor-1α, matrix metalloproteinase 9, tumor necrosis factor-α) and reduced fibrosis markers (fibronectin 1, α-smooth muscle actin) by targeting vascular endothelial growth factor. Fluorescence in situ hybridization indicated its expression localized to epidermal keratinocytes and fibroblasts in diabetic mice. Immunofluorescence revealed enhanced increased presence of M1 macrophages and reduced M2 polarization, highlighting its role in inflammation. MiR-122-5p elevated inflammatory cytokine levels while suppressing fibrotic activity from fibroblasts exposed to macrophage-derived media, highlighting its pivotal role in regulating DFU healing. CONCLUSION MiR-122-5p impedes cutaneous healing of diabetic mice via enhancing inflammation and inhibiting fibrosis, offering insights into miR roles in human skin wound repair.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Peripheral Vascular Surgery, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
- Department of Pathology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
- Department of Medical Oncology and Cancer Institute of Integrative Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
- Department of Peripheral Vascular Surgery, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. 15800885533@163.com.
Zitieren
APA
Yuan, M. J., Huang, H. C., Shi, H. S., Hu, X. M., Zhao, Z., Chen, Y. Q., Fan, W. J., Sun, J., & Liu, G. B. (2025). MicroRNA-122-5p is upregulated in diabetic foot ulcers and decelerates the transition from the inflammatory to the proliferative stage. World Journal of Diabetes, 16(4). https://doi.org/10.4239/wjd.v16.i4.100113
Vancouver
Yuan MJ, Huang HC, Shi HS, Hu XM, Zhao Z, Chen YQ, et al. MicroRNA-122-5p is upregulated in diabetic foot ulcers and decelerates the transition from the inflammatory to the proliferative stage. World Journal of Diabetes. 2025;16(4). doi:10.4239/wjd.v16.i4.100113
BibTeX
@article{Yuan2025,
author = {Yuan, Mei-Jie and Huang, He-Chen and Shi, Hong-Shuo and Hu, Xiao-Ming and Zhao, Zhuo and Chen, Yu-Qi and Fan, Wei-Jing and Sun, Jian and Liu, Guo-Bin},
title = {MicroRNA-122-5p is upregulated in diabetic foot ulcers and decelerates the transition from the inflammatory to the proliferative stage},
journal = {World Journal of Diabetes},
year = {2025},
volume = {16},
number = {4},
doi = {10.4239/wjd.v16.i4.100113}
}
EUVIMED